Quercetin-3-Glucoside from Ocimum basilicum ameliorates polycystic ovary syndrome by targeting the IL-6/JAK-STAT3 signaling axis
Journal of Reproductive Immunology · 2026-06 · 175 · 104905
DOI: 10.1016/j.jri.2026.104905 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Reproductive Immunology, 2026-06. Verfasst von Hina Majid Khan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, Atta Ur Rahman School of Applied Biosciences, National University of Sciences & Technology, H-12 Sector Main Campus, Islam…. Hauptthemen laut MEDLINE: Ocimum basilicum, Polycystic Ovary Syndrome, Quercetin. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National University of Science and Technology.
Abstract (Originalsprache)
Chronic inflammation is a key contributor to the pathophysiology of polycystic ovary syndrome (PCOS), disrupting hormonal signaling and ovarian function. This study investigated the therapeutic potential of Quercetin-3-Glucoside (Q3G), a bioactive flavonoid from Ocimum basilicum (OB), against PCOS-associated inflammation. An integrated approach of network pharmacology and molecular docking predicted Q3G interaction with key inflammatory targets IL6, STAT3, and BCL2, predominantly through the JAK-STAT signaling pathway. These predictions were validated in a letrozole-induced PCOS mouse model. Mice were divided into control, PCOS, PCOS+OB (125 mg/kg), OB-only, and PCOS+metformin groups over six weeks. The PCOS group exhibited increased body weight, hyperglycemia, elevated white blood cell count, hormonal imbalance (increased testosterone and LH/FSH ratio), disrupted estrous cyclicity, and ovarian morphological damage. Treatment with the OB ethanolic extract significantly ameliorated these metabolic, endocrine, and reproductive deficits. Furthermore, OB administration reduced oxidative stress by modulating SOD, catalase, and MDA levels, and downregulated the gene expression of IL6 and STAT3 while upregulating BCL2 in ovarian tissue. These findings demonstrate that Ocimum basilicum and its active component Q3G protect ovarian function in PCOS likely by suppressing the IL-6/JAK-STAT3 signaling axis, highlighting its promise as a natural therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedicine, Atta Ur Rahman School of Applied Biosciences, National University of Sciences & Technology, H-12 Sector Main Campus, Islamabad Capital Territory, Postal Code: 44000, Islamabad City, Pakistan.…
- Institute of Animal Sciences, Pir Mehr Shah Arid Agriculture University, (Postal Code: 46300),Rawalpindi, Pakistan. Electronic address: syedamaryam@uaar.edu.pk.
Förderung
- National University of Science and Technology
Zitieren
APA
Khan, H. M., Tarique, I., Zainab, M., Hussain, S. M., & Rehman, N. (2026). Quercetin-3-Glucoside from Ocimum basilicum ameliorates polycystic ovary syndrome by targeting the IL-6/JAK-STAT3 signaling axis. Journal of Reproductive Immunology, 175, 104905. https://doi.org/10.1016/j.jri.2026.104905
Vancouver
Khan HM, Tarique I, Zainab M, Hussain SM, Rehman N. Quercetin-3-Glucoside from Ocimum basilicum ameliorates polycystic ovary syndrome by targeting the IL-6/JAK-STAT3 signaling axis. Journal of Reproductive Immunology. 2026;175:104905. doi:10.1016/j.jri.2026.104905
BibTeX
@article{Khan2026,
author = {Khan, Hina Majid and Tarique, Imran and Zainab, Mohadsa and Hussain, Syeda Maryam and Rehman, Nimra},
title = {Quercetin-3-Glucoside from Ocimum basilicum ameliorates polycystic ovary syndrome by targeting the IL-6/JAK-STAT3 signaling axis},
journal = {Journal of Reproductive Immunology},
year = {2026},
volume = {175},
pages = {104905},
doi = {10.1016/j.jri.2026.104905}
}
EUVIMED